Nanoliposomal Irinotecan Fails to Boost Survival in Treated

No difference in PFS, median OS favored control group

Related Keywords

Paris , France General , France , Hannover , Niedersachsen , Germany , South Korea , Charles Bankhead , Coller Nanoliposomal , Linstitut Mutualiste Montsouris , David Malka , Arndt Vogel , Gastroenterol Hepatol , Hannover Medical School , , Lancet Gastroenterology , Medpage Today ,